Skip to content
Rio de Janeiro · São Paulo · Salvador — matters across Brazil
Bruno Marcelos — Escritório de Advocacia

Pauta Regulatória · Daily brief

No. 246

Automatically translated from the Portuguese edition, which prevails in case of discrepancy. Ler em português

Federal Official Gazette

No updates.

ANS news

Judicialization of health to be debated at Fonajus congress in Rio

The challenges of the judicialization of health in Brazil will be at the center of the debates at the V Congress of the National Judiciary Forum for Health, to be held on November 5 and 6, in Rio de Janeiro. The event is promoted by the National Council of Justice (CNJ), through the National Judiciary Forum for Health (Fonajus), in partnership with the Court of Justice of the State of Rio de Janeiro (TJRJ).

Held at the TJRJ headquarters, in the city center, the congress seeks to broaden technical knowledge about public and supplementary health and to promote reflection on the challenges of judicialization, focusing on the qualification and rationalization of lawsuits in the health field. The meeting is aimed at judges, representatives of the public and supplementary health sectors, and others interested in the topic.

The program includes four thematic workshops, which will address judicialization related to Autism Spectrum Disorder (ASD), cannabis products and oncological pharmaceutical assistance, as well as compliance with court decisions in health.

https://www.gov.br/ans/pt-br/assuntos/noticias-1/periodo-eleitoral/judicializacao-da-saude-sera-debatida-em-congresso-do-fonajus-no-rio

https://www.cnj.jus.br/agendas/v-congresso-nacional-do-fonajus/

Open public consultations

CP 176. Subject: preliminary recommendations against incorporation of the technology covered by UAT No. 184 – Molecular DNA analysis; search for microdeletions by FISH (Fluorescent In Situ Hybridization); microsatellite instability (MSI), detection by PCR, paraffin block, SUBITEM OF THE DUT – 110.39 – Syndrome of chromosomal anomalies not clinically recognizable (array). Deadline: September 21 to October 10, 2026.

CP 178. Subject: preliminary recommendations against incorporation of somatrogon and cabozantinib levomalate. Deadline: October 7 to 26, 2026.

Scheduled public hearings

No public hearing is scheduled.

Open public calls for input

The call for input directed to health plan operators’ ombudsman offices, concerning the resolution capacity of service channels and the monitoring provided for in RN No. 623/2024, is open until Oct 20.

Open public calls

There are no open public calls or targeted social participation procedures.

Other news

No updates.

Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.